RE:RE:think about thisI would take that a step further and say the share price doesn't even reflect a few hundred BioCloud units a month.
Even 300 units a month, assuming 12k CAD per unit is $43M in revenue on top of the core business.
The share price right now is disconnected from reality. Once we get a glimmer of sales, this will be quickly repriced and it won't come back down on these manipulated swing anymore.
It's a crazy good opportunity to accumulate right now.